Inhibition of platelet activation could decrease thrombotic events in hemodialysis PF4/H antibody-positive patients

References

• Yu Q, Yu H, Chen S, Wang L, Yuan W. Distribution and complications of native arteriovenous fistulas in maintenance hemodialysis patients: a single-center study. J Nephrol. 2011;24:597–603
   PubMed Web of Science ®Google Scholar
• Schwab SJ, Harrington JT, Singh A, et al. Vascular access for hemodialysis. Kidney Int. 1999;55:2078–2090
   PubMed Web of Science ®Google Scholar
• Chang JJ, Parikh CR. When heparin causes thrombosis: significance, recognition, and management of heparin-induced thrombocytopenia in dialysis patients. Semin Dial. 2006;19:297–304
   PubMed Web of Science ®Google Scholar
• Greinacher A, Althaus K, Krauel K, Selleng S. Heparin-induced thrombocytopenia. Hamostaseologie. 2010;30:17–18, 20–28
   PubMed Web of Science ®Google Scholar
• Kelton JG. Heparin-induced thrombocytopenia: an overview. Blood Rev. 2002;16:77–80
   PubMed Web of Science ®Google Scholar
• Warkentin TE. Heparin-induced thrombocytopenia: a clinicopathologic syndrome. Thromb Hemost. 1999;82:439–447
   PubMed Web of Science ®Google Scholar
• Mureebe L, Coats RD, Silliman WR, Shuster TA, Nichols WK, Silver D. Heparin-associated antiplatelet antibodies increase morbidity and mortality in hemodialysis patients. Surgery. 2004;136:848–853
   PubMed Web of Science ®Google Scholar
• Dixon BS, Beck GJ, Vazquez MA, et al. Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med. 2009;360:2191–2201
   PubMed Web of Science ®Google Scholar
• Dember LM, Beck GJ, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA. 2008;299:2164–2171
   PubMed Web of Science ®Google Scholar
• Wright RS, Reeder GS, Herzog CA, et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med. 2002;137:563–570
   PubMed Web of Science ®Google Scholar
• Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med. 2002;137:555–562
   PubMed Web of Science ®Google Scholar
• Pena de la Vega L, Miller RS, Benda MM, et al. Association of heparin-dependent antibodies and adverse outcomes in hemodialysis patients: a population-based study. Mayo Clin Proc. 2005;80:995–1000
   PubMed Web of Science ®Google Scholar
• lackCarrier M, Knoll GA, Kovacs MJ, Moore JC, Fergusson D, Rodger MA. The prevalence of antibodies to the platelet factor 4-heparin complex and association with access thrombosis in patients on chronic hemodialysis. Thromb Res. 2007;120:215–220
   PubMed Web of Science ®Google Scholar
• Alexy T, Tucker S, Boyle S, Rowe VL, Weaver FA, Liebman HA. Heparin-platelet factor 4 antibodies are frequent after vascular surgery but are not a frequent cause of graft thrombosis or thrombocytopenia. J Vasc Surg. 2008;48:377–381
   PubMed Web of Science ®Google Scholar
• Mattioli AV, Bonetti L, Carletti U, Ambrosio G, Mattioli G. Thrombotic events in patients with antiplatelet factor 4/heparin antibodies. Heart. 2009;95:1350–1354
   PubMed Web of Science ®Google Scholar
• Mattioli AV, Bonetti L, Zennaro M, Ambrosio G, Mattioli G. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up. Am Heart J. 2009;157:589–595
   PubMed Web of Science ®Google Scholar
• Lordkipanidze M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J. 2007;28:1702–1708
   PubMed Web of Science ®Google Scholar
• Harrison P, Frelinger AL 3rd, Furman MI, Michelson AD. Measuring antiplatelet drug effects in the laboratory. Thromb Res. 2007;120:323–336
   PubMed Web of Science ®Google Scholar
• Breet NJ, van Werkum JW, Bouman HJ, et al. Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. JAMA. 2010;303:754–762
   PubMed Web of Science ®Google Scholar
• Cattaneo M. Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance. Arterioscler Thromb Vasc Biol. 2004;24:1980–1987
   PubMed Web of Science ®Google Scholar
• Bevers EM, Comfurius P, Zwaal RF. Platelet procoagulant activity: physiological significance and mechanisms of exposure. Blood Rev. 1991;5:146–154
   PubMed Web of Science ®Google Scholar
• Gurbel PA, Tantry US, Shuldiner AR, Kereiakes DJ. Genotyping: one piece of the puzzle to personalize antiplatelet therapy. J Am Coll Cardiol. 2010;56:112–116
   PubMed Web of Science ®Google Scholar
• Kozinski M, Bielis L, Wisniewska-Szmyt J, et al. Diurnal variation in platelet inhibition by clopidogrel. Platelets. 2011;22:579–587
   PubMed Web of Science ®Google Scholar
• Kozinski M, Bielis L, Wisniewska-Szmyt J, et al. Increased morning ADP-dependent platelet aggregation persists despite dual antiplatelet therapy in patients with first ST-segment elevation myocardial infarction: preliminary report. Cardiol J. 2008;15:530–536
   PubMed Web of Science ®Google Scholar
• Michelson AD, Cattaneo M, Eikelboom JW, et al. Aspirin resistance: position paper of the Working Group on Aspirin Resistance. J Thromb Hemost. 2005;3:1309–1311
   Web of Science ®Google Scholar
• Kasprzak M, Kozinski M, Bielis L, et al. Pantoprazole may enhance antiplatelet effect of enteric-coated aspirin in patients with acute coronary syndrome. Cardiol J. 2009;16:535–544
   PubMed Web of Science ®Google Scholar
• Barton JF, Hardy AR, Poole AW, Mundell SJ. Reciprocal regulation of platelet responses to P2Y and thromboxane receptor activation. J Thromb Hemost. 2008;6:534–543
   Web of Science ®Google Scholar
• Cannon CP, Rhee KE, Califf RM, et al. Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry). Am J Cardiol. 2010;105:445–452
   PubMed Web of Science ®Google Scholar
• Kaufman JS, O'Connor TZ, Zhang JH, et al. Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. J Am Soc Nephrol. 2003;14:2313–2321
   PubMed Web of Science ®Google Scholar